
FDA cautions against off-label use of Pfizer/BioNTech Covid-19 vaccine in younger children
CNN
Even though the US Food and Drug Administration has fully approved the Pfizer/BioNTech Covid-19 vaccine for people age 16 and older, and it remains authorized for people as young as 12, the agency is warning against using the vaccine "off-label" in children younger than 12. To do so, it says, "would not be appropriate."
Off-label refers to an approved product being used in a way or in a patient that it wasn't necessarily approved for; it happens commonly with some drugs, such as when a chemotherapy approved for one type of cancer is used to treat a different type.More Related News

A little-known civil rights office in the Department of Education that helps resolve complaints from students across the country about discrimination and accommodating disabilities has been gutted by the Trump administration and is now facing a ballooning backlog, a workforce that’s in flux and an unclear mandate.












